Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

On November 5, 2025, argenx SE announced that Health Canada approved VYVGART SC (efgartigimod alfa injection) as a monotherapy for adults with active chronic inflammatory demyelinating polyneuropathy ...

CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada ...

Based on their findings, the authors concluded that the evaluation of the distribution of nerve enlargement offers significant diagnostic advantages. Nerve ultrasound is a “highly promising” tool for ...

People with CIDP had significantly higher total motor and cognitive fatigue scores compared with healthy people. According to a new study in the European Journal of Neurology, the full burden of ...

Learn to identify the early signs of Parkinson's disease so you can take action as soon as possible. Court Deals Blow to Trump Officials Over Veterans’ Cases Warren Buffett suggests all parents do one ...

Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare, multisystem, progressive, debilitating, and fatal disease characterized by tissue deposition of misfolded transthyretin ...

Death rates from chronic diseases fell in most countries around the world in the last decade. Despite a net improvement in such mortality, the U.S. was one of the worst performers among high-income ...

Brittany Lauro, 29, speaks to attendees at the second annual Walk & Roll event of the FSHD Society’s Sacramento chapter on September 7, 2025. Lauro was diagnosed with the muscular degenerative disease ...

Background: Intravenous immunoglobulin (IVIG) has been widely used to treat immune-mediated neuromuscular disorders. The relationship between IVIG and cancer is unclear. Preclinical studies have ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...